authors
- Duran, I
- Hotte, Sebastien
- Chen, E
- Hirte, H
- MacLean, M
- Turner, S
- Pond, Gregory
- Wright, J
- Dancey, J
- Siu, L
550 POSTER Dual inhibition of the MAPK pathway by combination targeted therapy: a phase I trial of sorafenib (SOR) and erlotinib (ERL) in advanced solid tumors
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2006
has subject area
- Oncology & Carcinogenesis (Science Metrix)